Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Total 13F shares
-
64,167,093
-
Share change
-
+3,065,443
-
Total reported value
-
$2,863,942,934
-
Put/Call ratio
-
23%
-
Price per share
-
$44.61
-
Number of holders
-
193
-
Value change
-
+$127,196,338
-
Number of buys
-
104
-
Number of sells
-
99
Institutional Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q1 2020
As of 31 Mar 2020,
PTC THERAPEUTICS, INC. - Common Stock (PTCT) was held by
193 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
64,167,093 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, BlackRock Inc., FMR LLC, RTW INVESTMENTS, LP, STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, and GREAT POINT PARTNERS LLC.
This page lists
194
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.